Brazil Hands Out Two Year Suspension to Olympian Silva

The CBDA has handed out their suspensions for the three athletes who had positive tests at the 2012 Maria Lenk Trophy.

The biggest, and most significant, was the suspension of Glauber Silva, who was subscribed to be on the 2012 Olympic Team in the 100 fly, for two years after it was revealed that he had abnormal levels of testosterone in his samples.

He argued in front of the doping panel on Tuesday that his urologist gave witness that he simply had an abnormal physiology, but the panel decided that his levels were consistent with exogenous (outside of the body) production.

Glauber Silva’s full ruling available here.

Pamela de Souza was hit with six months after testing positive for furosemide, which is the same substance for which Cesar Cielo and his teammates tested positive last year at the same meet.

The differences in suspensions between her and Cielo is a bit unusual; the panel concurred that there was no intent to gain an advantage, and that the concentration was too low to mask any substance, but handed out 6 months none-the-less.

Pamela de Souza full ruling available here.

Flavia Delaroli tested positive for a vasoconstrictor called tuaminoheptane. It is generally used in nasal decongestants. Vasoconstrictors shrink blood vessels, which would make it an unusual choice at a big meet. When people are intentionally doping using these substances, it’s usually in training where they’re training to force their body to adapt to the lower blood flows. But at meets, maximizing blood flow to the muscles is what increases performance.

She was handed only three months for her offense; though many expected that the Brazilian 50 free record holder was planning to retire at the end of the year anyway. The lighter suspension was because it was used in the form of a drug called Rhinoflumicil, which the federation was aware of, and was always declared in other tests. The caveat, however, is that she was only approved for use out of competition, and this was an in-competition test.

Full Delaroli ruling here.